Prevalence and risk factors of HBV, HCV, and HIV infections among cervical cancer patients

Purpose: The objective of this study was to evaluate the prevalence of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) infection and coinfection in patients with cervical cancer (CC), a public health problem. Materials and Methods: A retrospective study of HBV, HCV, and HIV in all patients from the Brazilian National Cancer Institute diagnosed with CC between 2009 and 2012 was performed. Results: A total of 1,659 patients were enrolled. Eighteen women (1.5%) were positive for HIV, 17 (1.2%) for hepatitis C, and 186 (13.9%) had prior exposure to HBV virus. Coinfection with HIV and HCV was detected in 0.3%, HCV and HBV in 0.2%, and HIV and HBV in 0.6% of the cases. Conclusion: CC patients have a higher prevalence of HIV and HBV infection than the general population in Brazil. The results support the importance of serological evaluation of patients recently diagnosed with CC, since these diseases have a common transmission path and the prognosis of CC can be influenced.

Cervical cancer; Hepatitis B; Hepatitis C; HIV infection; Coinfection.

[1] Ferlay J., Soerjomataram I., Ervik M., Dikshit R., Eser S., Mathers C., et al.: “GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11”. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed on 2014 July 05.

[2] Mathers C., Boerma T., Ma Fat. D. “The global burden of disease: 2004 update (Switzerland, World Health Organization, Geneva); 2008”. Available AT: http://www.who.int/healthinfo/global_burden_ disease/GBD_report_2004update_full.pdf, accessed on 2014 July 05.

[3] Kamangar F., Dores G.M., Anderson W.F. “Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world”. J. Clin. Oncol., 2006, 24, 2137.

[4] WHO/ICO Information Center of HPV and Cervical Cancer (HPV Information Center). Human Papillomavirus and Related Cancers in the World. Summary Report 2010 [Internet]. Available at: http://www.who.int/hpvcentre/en/

[5] Rio de Janeiro (RJ) Instituto Nacional do Câncer Brasil: “Estimativa 2014 Incidência do Câncer no Brasil”. Available at: http://www1.inca.gov.br/estimativa/2014, accessed on 2015 Feb 11.

[6] DeVita V.T. Jr., Hellman S., Rosenberg S.A. “Cancer - Principles & Practice of Oncology”. 9thed. Baltimore: Lippincott: Williams & Wilkins, 2011.

[7] Forman D., de Martel C., Lacey C.J., Soerjomataram I., Lortet Tieulent J., Bruni L., et al. “Global burden of human papillomavirus and related diseases”. Vaccine, 2012, 20, 30 Suppl 5:F12-23.

[8] Bomfim-Hyppólito S., Eleuterio J. Jr., Nunes G.C., Bomfim-Hyppólito E., Franco E.S., Neto Rda. J. “HIV or human papillomavirus co-infection among Brazilian individuals infected with hepatitis B and/or hepatitis C”. Int J Gynaecol Obstet., 2013, 122, 258-60.

[9] Meyrelles A.R., Siqueira J.D., Hofer C.B., Costa T.P., Azevedo A.P., Guimarães B.V., et al.: “HIV/HPV co-infection during pregnancy in southeastern Brazil: prevalence, HPV types, cytological abnormalities and risk factors”. Gynecol. Oncol., 2013, 128, 107..

[10] Global report: UNAIDS report on the global AIDS epidemic 2013. “UNAIDS / JC2502/1/E” Available at: http://www.unaids.org/sites/ default/files/en/media/unaids/vcontentassets/documents/epidemiology/ 2013/gr2013/UNAIDS_Global_Report_2013_en.pdf

[11] Departamento de DST, Aids e hepatites virais, Brazil: “Aids no Brasil”. Available at: http://www.aids.gov.br/pagina/aids-no-brasil

[12] “Estudo da prevalência de base populacional das infecções pelo vírus das hepatites A, B, e C nas capitais do Brasil”, Brazil. Brasilia, DF: Ministerio da Saude, 2010. Available at: http://www.aids.gov. br/sites/default/files/anexos/publicacao/2010/50071/estudo_prevalencia_ hepatites_pdf_26830.pdf, accessed on 2014 July 5.

[13] Frisch M., Biggar R.J., Goedert J.J. “Human papillomavirus associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome”. J. Natl. CancerInst., 2000, 92, 1500.

[14] Moreira M., Ramos A., Netto E.M., Brites C. “Characteristics of coinfections by HCV and HBV among Brazilian patients infected by HIV-1 and/or HTLV-1”. Braz. J. Infect. Dis., 2013, 17, 661.

[15] Ximenes R.A., Pereira L.M., Martelli C.M., Merchán-Hamann E., Stein A.T., Braga M.C., et al.: “Methodology of a nationwide crosssectional survey of prevalence and epidemiological patterns of hepatitis A, B and C infection in Brazil”. Cad .Saude. Publica, 2010, 26, 1693.

[16] Pereira L.M., Martelli C.M., Moreira R.C., Merchan-Hamman E., Stein A.T., Cardoso M.R., et al.: “Prevalence and risk factors of Hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional study”. BMC Infect. Dis., 2013, 13, 60.

[17] “From the Centers for Disease Control and Prevention: “1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults”. JAMA, 1993, 269, 729.

[18] Paim J., Travassos C., Almeida C., Bahia L., Macinko J.: “The Brazilian health system: history, advances, and challenges”. Lancet, 2011, 377, 1778.

[19] “HIV and Viral Hepatitis”. Available at: http://www.cdc.gov/hiv/pdf/library_factsheets_HIV_and_viral_Hepatitis.pdf